Medicare limits coverage of $28,000-a-year Alzheimer's drug Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer's drug whose benefits have been widely questioned, a major development in the nation's tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices. Health 12 Jan, 2022
FDA trims use of contentious Alzheimer's drug amid backlash A month after approving a controversial new Alzheimer's drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use. World 09 Jul, 2021
Alzheimer's drug stirs hope for patients, worry for doctors Alzheimer's drug stirs hope for patients, worry for doctors Health 27 Jun, 2021
FDA approves much-debated Alzheimer's drug panned by experts Government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. Health 09 Jun, 2021
US states race to contain coronavirus as cases exceed 1,000 NEW YORK: As coronavirus cases crop up across the United States, some governors and other leaders are scrambling to slow its spread, banning large public gatherings, enforcing quarantines and calling National Guard troops. With new deaths reported...
